Paul W. Tebbey, PhD, MB

Dr Paul W. Tebbey is Therapeutic Area Head, Oncology, US Medical Affairs, Abbvie, based in Chicago, IL, USA. He has over 20 years of healthcare experience across the biotechnology and pharmaceutical sectors. Dr Tebbey received a PhD in Microbiology and Immunology from East Carolina University School of Medicine (Greenville, NC) where his research focused on T lymphocyte cell signalling and immunosuppression. Subsequent to his postdoctoral studies at Vanderbilt University (Nashville, TN), which focused on the regulation of gene expression, he then studied for a MBA at Rochester Institute of Technology (Rochester, NY). Dr Tebbey’s research, development and launch experiences include complex biotechnological therapies, including the monoclonal antibodies adalimumab, infliximab and ustekinumab, as well as complex vaccines, in particular, a conjugated pneumococcal vaccine. Dr Tebbey’s publications include over 40 peer-reviewed articles that span immunology, immune-mediated and infectious diseases, as well as pharmaceutical publication planning and brand success.

Stay Connected with MAPS

Join MAPS on LinkedIn to further build your professional connections within Medical Affairs through our Company and Group Pages.


Follow us on Twitter and say abreast of MAPS activities and key issues for Medical Affairs professionals.